TRACEY HENSLEE: Open Payments
NPI 1326369752 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 24 payments from 5 companies in 2025. Trend: 2023 $149 · 2024 $325 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $249 |
| ABBVIE INC. | 8 | $241 |
| Organon LLC | 5 | $78 |
| UCB, Inc. | 1 | $31 |
| Incyte Corporation | 1 | $14 |
Products named: RINVOQ, COSENTYX, Rhapsido, Opzelura, SKYRIZI, VTAMA.
Industry payments across AL — which companies pay providers there.
